Genome‐scale Metabolic Modeling Guided Escherichia coli Engineering for De Novo Biosynthesis of Chrysanthemic Acid
Advanced Science · 2026
DOI: 10.1002/advs.202512736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Jiangpeng Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Branch, Guangdong Laboratory of Lingnan Modern Agriculture, Key Laboratory of Synthetic Biology, Ministry of Agriculture and Rural Affairs, …. Hauptthemen laut MEDLINE: Escherichia coli, Metabolic Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Shenzhen Science and Technology Program.
Abstract (Originalsprache)
Chrysanthemic acid is an unconventional monoterpene moiety of the natural pesticide pyrethrins with notable anti‐insect activity, making its industrial biosynthesis a promising avenue for sustainable agriculture. Here, an E. coli cell factory is designed and build for highly efficient chrysanthemic acid production guided by Genome‐scale metabolic models (GEM). The biosynthetic pathway is reconstructed and simulated the metabolic changes caused by exogenous modules are simulated. A key metabolic branch point catalyzed by ispA is identified by this model, and inhibiting its expression using synthetic small RNA redirected the metabolic flux, resulting in the titers of precursor chrysanthemol and chrysanthemic acid increasing by 162% and 59%, respectively. The effect of the expression level of downstream dehydrogenases on chrysanthemic acid titer is also predicated using GEM, and the further optimization of copy number for dehydrogenase genes led to a notably 570% increase in chrysanthemic acid titer experimentally. By integrating the debranching strategy with copy number optimization, a record chrysanthemic acid titer 141.78 mg L −1 is achieved in a bioreactor. The work seamlessly integrated in silico modeling optimization with wet‐lab practices that significantly enhance target metabolite titer through metabolic network engineering, offering a new route for constructing efficient cell factories for natural bioproducts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shenzhen Branch, Guangdong Laboratory of Lingnan Modern Agriculture, Key Laboratory of Synthetic Biology, Ministry of Agriculture and Rural Affairs, Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricu…
- College of Plant & Technology, Huazhong Agricultural University, Wuhan, 430070, China.
- National Key Laboratory of Agricultural Microbiology, College of Life Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China.
ORCID-Profile: Wei Li
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Shenzhen Science and Technology Program
- National Key Research and Development Program of China
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Yu, J., Cheng, K., Qu, S., Wang, J., Wang, X., Zhao, C., & Li, W. (2026). Genome‐scale Metabolic Modeling Guided Escherichia coli Engineering for De Novo Biosynthesis of Chrysanthemic Acid. Advanced Science. https://doi.org/10.1002/advs.202512736
Vancouver
Yu J, Cheng K, Qu S, Wang J, Wang X, Zhao C, et al. Genome‐scale Metabolic Modeling Guided Escherichia coli Engineering for De Novo Biosynthesis of Chrysanthemic Acid. Advanced Science. 2026. doi:10.1002/advs.202512736
BibTeX
@article{Yu2026,
author = {Yu, Jiangpeng and Cheng, Kelin and Qu, Shenyang and Wang, Jie and Wang, Xun and Zhao, Cheng and Li, Wei},
title = {Genome‐scale Metabolic Modeling Guided Escherichia coli Engineering for De Novo Biosynthesis of Chrysanthemic Acid},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202512736}
}
EUVIMED